Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
The M20 IL-1 inhibitor prevents onset of adjuvant arthritis
Vivian Barak
*
, David Peritt
, Iancu Flechner
, Yoav Sherman
,
Elimelech Okon
, Peter Yanai
, Tal Halperin
, Abraham J. Treves
*
Corresponding author for this work
Hadassah University Medical Centre
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The M20 IL-1 inhibitor prevents onset of adjuvant arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Arthritis
100%
IL-1 Inhibitors
100%
Interleukin-1β
71%
Rheumatoid Arthritis
42%
Freund Incomplete Adjuvant
28%
Fever
14%
Lewis Rats
14%
After Injection
14%
Histological Examination
14%
Inhibitory Activity
14%
Pathological Process
14%
Leukocytosis
14%
No Adverse Effect
14%
In Vitro Activity
14%
Footpad
14%
Acute Phase Reactants
14%
Chronic Inflammation
14%
Erythema
14%
Joint Inflammation
14%
Joint Fluid
14%
Lymph Node Enlargement
14%
Joint Swelling
14%
Joint Destruction
14%
Acute Inflammatory Reaction
14%
Periarticular
14%
Myelomonocytic Cells
14%
Elevated Levels
14%
Dose-dependent
14%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 1
100%
Adjuvant-Induced Arthritis
100%
Adjuvant Arthritis
100%
Rheumatoid Arthritis
25%
Inflammatory Arthritis
25%
Freund's Adjuvant
16%
Rat
16%
Inflammation
8%
Tumor Necrosis Factor
8%
Cytokine
8%
Leukocytosis
8%
Lewis Rat
8%
Arthritis
8%
Acute Phase Protein
8%
Chronic Inflammation
8%
Lymphadenopathy
8%
Erythema
8%
Joint Destruction
8%
Joint Swelling
8%
Adverse Effect
8%